Tissue microarray technology for high-throughput molecular profiling of cancer.
about
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulatorsTmaDB: a repository for tissue microarray dataMolecular pathology in epidemiologic studies: a primer on key considerationsExpression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarrayH-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signalingGenetic alteration and gene expression modulation during cancer progressionTissue Microarray Analysis Applied to Bone DiagenesisThe tissue microarray data exchange specification: Extending TMA DES to provide flexible scoring and incorporate virtual slidesRoadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in OncologyContributions of proteome profiling to the molecular analysis of cancer.Segment and fit thresholding: a new method for image analysis applied to microarray and immunofluorescence data.Expression profiling of microdissected pancreatic adenocarcinomas.TMAinspiration: Decode Interdependencies in Multifactorial Tissue Microarray Data.Understanding cancer through proteomics.Antibodypedia, a portal for sharing antibody and antigen validation data.COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situDetection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancerNuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.Argonaute proteins: potential biomarkers for human colon cancerBreast Biomarkers-Comparison on Whole Section and Tissue Microarray Section.Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray.Prognostic impact of lymphocytes in soft tissue sarcomasThe phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples.Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.Automatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkersIdentification of prognostic biomarkers for glioblastomas using protein expression profiling.CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.An gene expression pattern.Novel translational strategies in colorectal cancer research.Antibody-based proteomics for human tissue profiling.Application of new tissue microarrayer-ZM-1 without recipient paraffin block.Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.Expression profile and prognostic role of sex hormone receptors in gastric cancerLack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in miceBmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancerPrognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
P2860
Q24303946-CE572550-5E68-4D7A-B8E3-57677EC44CADQ24534015-F2D107BB-53B0-42AC-9574-D6732B93B9D9Q24598972-9052C78D-2198-417A-B567-9B590219DE72Q24657451-85167BEB-27B0-45BA-9CB5-5D9A1C4CE2C0Q24671049-15648D3B-CA8F-445F-8262-FBFCC71BD4E9Q24798750-70CB9F7B-A017-456E-9412-AE1454E6F14DQ28584479-6ED19B0F-1572-445A-8D22-F0FA6B628AC7Q28741290-FAC81D1E-5276-48C5-8C82-12A720C7E6A0Q30352887-C1685023-4E0F-4807-979C-8EF6F733E982Q30893357-F589BA8D-018E-4258-ABFE-B08F634AD71AQ30991545-2BE1201D-93C0-438A-969D-AF868A805BD3Q31088417-DDF55087-43D9-42BB-AEB8-CB9522D0E196Q31113719-9D5F4ACE-6DD1-4C51-B790-826EF3C29AB1Q31134537-DA3CDBA5-A921-4F5D-AF68-D3138D2DA1E9Q31166222-1DA6E580-C778-4340-8497-5DCED14C2A25Q33317621-0A082D76-FDBD-4EAA-8FF8-BCBA7752330AQ33318711-7B6DCE69-3E69-4043-9856-A38CEBC24A07Q33343565-96E0F89B-6E0C-49A9-9CBE-8591CAF71F7CQ33530549-3ACEB9A7-C9BF-41A0-B545-CB0F92027CD5Q33666339-E6430387-0721-4C28-8C88-DEE43734EB2DQ33688929-9C1E975F-425F-4E87-8B61-C4CA5BA919BCQ33787998-ED2506BD-AE13-40D2-8984-B383AFE735A9Q33813250-79C33598-6F06-4B3C-85C7-6100351BC97BQ33906083-51FEE79D-8C9E-490E-B2DF-D3CBC00E5077Q33919227-E6A04938-7AF1-4689-A36A-44C92AC61E8CQ34033355-56DBDBBB-28E4-40C4-AC03-8D6E2CA0DF5EQ34098960-78AE15C7-C180-4432-96F5-C3167AFA3E2BQ34104795-D7B03F0B-6781-499C-AC94-7015EF304928Q34157312-CAA59DA5-A394-4F5E-AC48-C5F3BD02D78DQ34247041-E8EB0E03-4CF7-46A8-B159-B8B45E4F0677Q34300764-6BAC3C95-8539-4CAD-9A9C-ED9B079FE1D8Q34382804-14DE1BAF-7D70-40C2-A399-B4E3DCA90ECEQ34391731-A60CDF86-55BB-463A-856F-C1698D9A0870Q34425688-2B19BEC4-FF54-4F90-B31C-AA0BA4716B37Q34447850-63634DA9-2F58-490F-8214-90375DEE8F0CQ34496830-96CDF4FD-1A14-4396-A485-2FCE391C1CF1Q34502296-13CA5573-A167-4D09-B76B-128DC69AD2DBQ34519881-2291A760-9536-4B16-869A-47D49DC5B67EQ34570526-F8950DCB-10EB-4FEB-B019-5BE147D12BF8Q34622739-593D6CD4-CC72-4F10-8E4A-FA2AF5219451
P2860
Tissue microarray technology for high-throughput molecular profiling of cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tissue microarray technology for high-throughput molecular profiling of cancer.
@ast
Tissue microarray technology for high-throughput molecular profiling of cancer.
@en
Tissue microarray technology for high-throughput molecular profiling of cancer.
@nl
type
label
Tissue microarray technology for high-throughput molecular profiling of cancer.
@ast
Tissue microarray technology for high-throughput molecular profiling of cancer.
@en
Tissue microarray technology for high-throughput molecular profiling of cancer.
@nl
prefLabel
Tissue microarray technology for high-throughput molecular profiling of cancer.
@ast
Tissue microarray technology for high-throughput molecular profiling of cancer.
@en
Tissue microarray technology for high-throughput molecular profiling of cancer.
@nl
P2093
P356
P1476
Tissue microarray technology for high-throughput molecular profiling of cancer.
@en
P2093
P304
P356
10.1093/HMG/10.7.657
P577
2001-04-01T00:00:00Z